Discontinued — last reported Q4 '25
Linde Business Sale Proceeds increased by 57.1% to $11.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 31.3%, from $16.00M to $11.00M. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -29.2% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $70.00M | $20.00M | $27.00M | -$10.00M | $123.00M | $55.00M | $3.00M | $21.00M | $10.00M | $36.00M | $7.00M | $15.00M | $132.00M | $16.00M | $13.00M | $11.00M | $7.00M | $11.00M |
| QoQ Change | — | +25.0% | -71.4% | +35.0% | -137.0% | >999% | -55.3% | -94.5% | +600.0% | -52.4% | +260.0% | -80.6% | +114.3% | +780.0% | -87.9% | -18.8% | -15.4% | -36.4% | +57.1% |
| YoY Change | — | — | — | — | -117.9% | +75.7% | +175.0% | -88.9% | +310.0% | -91.9% | -34.5% | +133.3% | -28.6% | >999% | -55.6% | +85.7% | -26.7% | -94.7% | -31.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.